TuHURA Biosciences Inc (HURA) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.65x
TuHURA Biosciences Inc (HURA) has a Cash Flow-to-Debt Ratio of -0.65x as of June 2026, meaning its operating cash flow of $-8.63 Million could theoretically repay -1% of its total liabilities ($13.25 Million) in one year. See TuHURA Biosciences Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.65x
Operating CF / Total Liabilities
Operating Cash Flow
$-8.63 Million
USD
Total Liabilities
$13.25 Million
USD
Data as of
Jun 2026
Most recent filing
TuHURA Biosciences Inc Cash Flow-to-Debt Ratio (2014–2026)
Historical debt coverage capacity for TuHURA Biosciences Inc across 13 annual periods. For the full cash flow conversion analysis, see how efficiently does TuHURA Biosciences Inc generate cash.
Annual Cash Flow-to-Debt Ratio for TuHURA Biosciences Inc (2014–2026)
Year-by-year debt coverage analysis for TuHURA Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -4.30x | $-27.63 Million | $6.42 Million | ▼ -57.0% |
| 2025 | -2.74x | $-14.73 Million | $5.37 Million | ▼ -35.8% |
| 2024 | -2.02x | $-11.95 Million | $5.92 Million | ▲ +22.2% |
| 2023 | -2.60x | $-7.51 Million | $2.89 Million | ▼ -182.8% |
| 2022 | -0.92x | $-6.56 Million | $7.15 Million | ▲ +85.6% |
| 2021 | -6.37x | $-18.86 Million | $2.96 Million | ▼ -114.8% |
| 2020 | -2.96x | $-7.93 Million | $2.67 Million | ▲ +3.1% |
| 2019 | -3.06x | $-6.33 Million | $2.07 Million | ▲ +49.1% |
| 2018 | -6.01x | $-9.85 Million | $1.64 Million | ▲ +0.2% |
| 2017 | -6.02x | $-8.02 Million | $1.33 Million | ▼ -75.1% |
| 2016 | -3.44x | $-5.15 Million | $1.50 Million | ▼ -203.0% |
| 2015 | -1.13x | $-3.85 Million | $3.40 Million | ▼ -5.5% |
| 2014 | -1.07x | $-5.52 Million | $5.14 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.